HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Michael Benatar Selected Research
Michael Benatar Research Topics
Disease
32
Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
10/2022 - 04/2007
24
Myasthenia Gravis
12/2021 - 07/2006
7
Disease Progression
01/2022 - 05/2011
4
Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 03/2013
3
Asymptomatic Diseases
01/2022 - 01/2018
3
Frontotemporal Dementia (Semantic Dementia)
01/2022 - 01/2012
3
Spinal Muscular Atrophy (Progressive Muscular Atrophy)
01/2022 - 02/2015
2
Headache (Headaches)
01/2021 - 12/2017
2
Thymoma (Thymic Carcinoma)
11/2020 - 12/2017
2
Motor Neuron Disease (Primary Lateral Sclerosis)
01/2020 - 01/2011
2
Infections
12/2016 - 05/2010
2
Proteostasis Deficiencies
05/2013 - 03/2013
2
Ischemic Stroke
02/2009 - 01/2008
1
Alzheimer Disease (Alzheimer's Disease)
01/2022
1
Parkinson Disease (Parkinson's Disease)
01/2022
1
Inflammation (Inflammations)
08/2021
1
Meningococcal Infections
01/2019
1
Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
01/2019
1
Fatigue
01/2018
1
Meningococcal Meningitis
12/2017
1
Respiratory Tract Infections (Respiratory Tract Infection)
12/2017
1
Thymus Neoplasms (Thymus Neoplasm)
12/2017
1
Guillain-Barre Syndrome
12/2016
1
Respiratory Insufficiency (Respiratory Failure)
12/2016
1
Autonomic Nervous System Diseases (Dysautonomia)
12/2016
1
Vascular Diseases (Vascular Disease)
07/2015
1
Autoimmune Diseases (Autoimmune Disease)
04/2015
1
Hypertrophy
02/2015
1
Parkinsonian Disorders (Parkinsonism)
04/2012
1
Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
01/2012
1
Muscular Diseases (Myopathy)
01/2012
1
Nervous System Diseases (Neurological Disorders)
01/2012
Drug/Important Bio-Agent (IBA)
18
Biomarkers (Surrogate Marker)
IBA
01/2022 - 11/2010
11
Cholinergic Receptors
IBA
12/2021 - 07/2006
7
Biological Products
IBA
10/2022 - 05/2013
7
Proteins (Proteins, Gene)
FDA Link
01/2021 - 01/2012
4
Rituximab (Mabthera)
FDA Link
12/2021 - 09/2017
4
Antibodies
IBA
01/2021 - 07/2006
4
Prednisone (Sone)
FDA Link
Generic
11/2020 - 03/2016
3
glucose-mannose-glucose
IBA
01/2021 - 01/2019
3
Heat-Shock Proteins (Heat-Shock Protein)
IBA
02/2020 - 01/2018
3
Pharmaceutical Preparations
IBA
01/2020 - 02/2009
3
Cholinesterase Inhibitors (Anticholinesterases)
IBA
01/2019 - 06/2007
3
Edrophonium (Tensilon)
FDA Link
Generic
01/2019 - 07/2006
3
Intravenous Immunoglobulins (IVIG)
FDA Link
12/2017 - 10/2013
3
Steroids
IBA
07/2016 - 10/2008
3
Valosin Containing Protein
IBA
09/2012 - 12/2010
2
Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)
IBA
01/2022 - 03/2017
2
margatoxin
IBA
11/2020 - 01/2019
2
Complement Inactivating Agents
IBA
01/2020 - 12/2017
2
Phosphotransferases (Kinase)
IBA
01/2019 - 09/2017
2
Adrenal Cortex Hormones (Corticosteroids)
IBA
01/2019 - 12/2012
2
eculizumab
FDA Link
01/2019 - 12/2017
2
Pyridostigmine Bromide (Pyridostigmine)
FDA Link
Generic
03/2016 - 02/2008
2
Amino Acids
FDA Link
03/2013 - 12/2010
2
Nicotinic Receptors (Nicotinic Acetylcholine Receptor)
IBA
02/2010 - 02/2008
1
Amyloid (Amyloid Fibrils)
IBA
01/2022
1
C-Reactive Protein
IBA
01/2022
1
tofersen
IBA
01/2022
1
Neopterin
IBA
01/2022
1
Edaravone
IBA
08/2021
1
neonatal Fc receptor
IBA
01/2021
1
RNA (Ribonucleic Acid)
IBA
01/2021
1
Monoclonal Antibodies
IBA
01/2021
1
Antigen-Antibody Complex (Immune Complex)
IBA
01/2021
1
rozanolixizumab
IBA
01/2021
1
Dipeptides
IBA
01/2021
1
Chitinases
IBA
01/2020
1
zilucoplan
IBA
01/2020
1
Autoantibodies
IBA
01/2020
1
rho-Associated Kinases
IBA
01/2019
1
Peptides (Polypeptides)
IBA
01/2019
1
fasudil (AT 877)
IBA
01/2019
1
Antisense Oligonucleotides
IBA
01/2019
1
polyetheretherketone
IBA
01/2018
1
arimoclomol
IBA
01/2018
1
Complement System Proteins (Complement)
IBA
12/2017
1
Dihydrotachysterol (AT 10)
IBA
09/2017
1
Immunosuppressive Agents (Immunosuppressants)
IBA
09/2017
1
Methotrexate (Mexate)
FDA Link
Generic
07/2016
1
Retinaldehyde (Retinal)
IBA
07/2015
1
DNA (Deoxyribonucleic Acid)
IBA
04/2015
1
Immunomodulating Agents
IBA
04/2015
1
Cytoplasmic Dyneins
IBA
02/2015
1
RNA-Binding Proteins (RNA-Binding Protein)
IBA
03/2013
1
Glycine (Aminoacetic Acid)
FDA Link
Generic
03/2013
1
Heterogeneous-Nuclear Ribonucleoproteins (Informatin)
IBA
03/2013
1
Prions
IBA
03/2013
1
Superoxide Dismutase-1
IBA
03/2013
1
Azathioprine (Imuran)
FDA Link
Generic
12/2012
Therapy/Procedure
17
Therapeutics
01/2022 - 04/2007
6
Thymectomy
11/2020 - 10/2013
2
Activities of Daily Living (ADL)
12/2017 - 07/2016
2
Plasma Exchange
12/2017 - 10/2013
1
Noninvasive Ventilation
12/2016
1
Physical Therapy Modalities (Physical Therapy Technique)
12/2016
1
Immunotherapy
12/2016
1
Plasmapheresis
12/2016
1
Artificial Respiration (Mechanical Ventilation)
12/2016
1
Denervation
02/2015